← Latest Filings
K

Khan Najat

CEO and President

Open-market buys
0
$0 total
Open-market sells
4
$807K total
Tracking since
Dec 2025
Activity timeline
Open-market sale — $79K
RECURSION PHARMACEUTICALS, INC. · Sep 8, 2026
Open-market sale — $84K
RECURSION PHARMACEUTICALS, INC. · Jun 5, 2026
Open-market trades from the last two years.

2 more trades. A free account shows you more; Premium shows every one.

Log in
Holdings as last reported
2,072,890 Class A Common Stock in RXRX
Held directly · as of 2026-09-08
993,944 Stock Option (Right to Buy) in RXRX
Held directly · as of 2025-12-22

2 more holdings. A free account shows you more; Premium shows every one.

Log in
Companies touched
RECURSION PHARMACEUTICALS, INC.
CIK 0001601830